• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于流式细胞术的结合测定法用于评估识别表皮生长因子受体的单克隆抗体的验证

Validation of a flow cytometry based binding assay for evaluation of monoclonal antibody recognizing EGF receptor.

作者信息

Cedeño-Arias Mercedes, Sánchez-Ramírez Javier, Blanco-Santana Rancés, Rengifo-Calzado Enrique

机构信息

Center of Molecular Immunology, 216 St and 15 Ave. Atabey, Playa. POBox 16040, Havana 11600, Cuba.

出版信息

Sci Pharm. 2011 Jul-Sep;79(3):569-81. doi: 10.3797/scipharm.1104-18. Epub 2011 Jul 3.

DOI:10.3797/scipharm.1104-18
PMID:21886904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3163362/
Abstract

An ideal test used to characterize a product must be appropriate for the measurement of product quality, manufacturing consistency, product stability, and comparability studies. Flow cytometry has been successfully applied to the examination of antibodies and receptors on membrane surfaces; however, to date, the analytical validation of cytometry based assays is limited. Here we report on the validation of a flow cytometry-based assay used in the evaluation of nimotuzumab binding to cells over-expressing EGFR on cell surface. The assay was validated by examining, assay robustness, specificity, repeatability and intermediate precision. The assay was highly specific, robust for all studied factors except for cell fixation with 1% paraformaldehyde and met criteria for precision with RSD < 2%. In addition the assay has stability-indicating properties evidenced by the ability to detect changes in mAb degraded samples. Most importantly, the assay demonstrated to be useful for its intended use.

摘要

用于表征产品的理想测试必须适用于产品质量、生产一致性、产品稳定性和可比性研究的测量。流式细胞术已成功应用于膜表面抗体和受体的检测;然而,迄今为止,基于细胞术的检测方法的分析验证是有限的。在此,我们报告一种基于流式细胞术的检测方法的验证,该方法用于评估尼妥珠单抗与细胞表面过度表达表皮生长因子受体(EGFR)的细胞的结合情况。通过检测该检测方法的稳健性、特异性、重复性和中间精密度对其进行了验证。该检测方法具有高度特异性,除了用1%多聚甲醛固定细胞外,对所有研究因素均具有稳健性,并且符合精密度标准,相对标准偏差(RSD)<2%。此外,该检测方法具有稳定性指示特性,这通过检测单克隆抗体降解样品中的变化的能力得到证明。最重要的是,该检测方法已证明对其预期用途有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e39/3163362/4ae501eb278f/Scipharm-2011-79-569f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e39/3163362/9fca352509d5/Scipharm-2011-79-569f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e39/3163362/a4e179f19dde/Scipharm-2011-79-569f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e39/3163362/4ae501eb278f/Scipharm-2011-79-569f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e39/3163362/9fca352509d5/Scipharm-2011-79-569f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e39/3163362/a4e179f19dde/Scipharm-2011-79-569f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e39/3163362/4ae501eb278f/Scipharm-2011-79-569f3.jpg

相似文献

1
Validation of a flow cytometry based binding assay for evaluation of monoclonal antibody recognizing EGF receptor.一种基于流式细胞术的结合测定法用于评估识别表皮生长因子受体的单克隆抗体的验证
Sci Pharm. 2011 Jul-Sep;79(3):569-81. doi: 10.3797/scipharm.1104-18. Epub 2011 Jul 3.
2
Validation of a flow cytometry based chemokine internalization assay for use in evaluating the pharmacodynamic response to a receptor antagonist.用于评估对受体拮抗剂药效学反应的基于流式细胞术的趋化因子内化测定法的验证
J Transl Med. 2008 Dec 1;6:76. doi: 10.1186/1479-5876-6-76.
3
Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients.验证用于检测黑色素瘤患者对gp100和MelanA/MART-1免疫反应的HLA-A2四聚体流式细胞术方法、IFNγ实时逆转录聚合酶链反应以及IFNγ酶联免疫斑点法。
J Transl Med. 2008 Oct 22;6:61. doi: 10.1186/1479-5876-6-61.
4
Validation of a flow cytometry based G(2)M delay cell cycle assay for use in evaluating the pharmacodynamic response to Aurora A inhibition.基于流式细胞术的 G(2)/M 期延迟细胞周期检测方法的验证,用于评估 Aurora A 抑制的药效反应。
J Immunol Methods. 2011 Jan 5;363(2):135-42. doi: 10.1016/j.jim.2010.09.021. Epub 2010 Sep 29.
5
Validation of a quantitative flow cytometer assay for monitoring HER-2/neu expression level in cell-based cancer immunotherapy products.
Biologicals. 2010 Mar;38(2):249-59. doi: 10.1016/j.biologicals.2009.12.001. Epub 2010 Jan 15.
6
Development and validation of a high-parameter mass cytometry workflow to decipher immunomodulatory changes in celiac disease.开发和验证高通量质谱细胞术工作流程,以解析乳糜泻中的免疫调节变化。
Cytometry B Clin Cytom. 2021 Jan;100(1):92-102. doi: 10.1002/cyto.b.21986. Epub 2021 Jan 16.
7
Development and validation of a bioassay to evaluate binding of adalimumab to cell membrane-anchored TNFα using flow cytometry detection.开发并验证了一种使用流式细胞术检测评估阿达木单抗与细胞膜锚定 TNFα 结合的生物分析方法。
J Pharm Biomed Anal. 2018 Jun 5;155:235-240. doi: 10.1016/j.jpba.2018.03.057. Epub 2018 Mar 30.
8
Bivalent binding by intermediate affinity of nimotuzumab: a contribution to explain antibody clinical profile.尼妥珠单抗的中等亲和力的双价结合:对解释抗体临床特征的贡献。
Cancer Biol Ther. 2011 Feb 15;11(4):373-82. doi: 10.4161/cbt.11.4.14097.
9
Development and Validation of an Affinity Chromatography-Protein G Method for IgG Quantification.用于IgG定量的亲和色谱-蛋白G方法的开发与验证
Int Sch Res Notices. 2014 Oct 27;2014:487101. doi: 10.1155/2014/487101. eCollection 2014.
10
Complement dependent cytotoxicity (CDC) activity of a humanized anti Lewis-Y antibody: FACS-based assay versus the 'classical' radioactive method -- qualification, comparison and application of the FACS-based approach.人源化抗Lewis-Y抗体的补体依赖细胞毒性(CDC)活性:基于流式细胞术的检测方法与“经典”放射性方法的比较——基于流式细胞术方法的鉴定、比较及应用
J Pharm Biomed Anal. 2009 May 1;49(4):1014-20. doi: 10.1016/j.jpba.2009.01.029. Epub 2009 Feb 4.

引用本文的文献

1
Applications of Surface Plasmon Resonance and Biolayer Interferometry for Virus-Ligand Binding.表面等离子体共振和生物层干涉技术在病毒配体结合中的应用。
Viruses. 2022 Mar 29;14(4):717. doi: 10.3390/v14040717.
2
Polymalic acid chlorotoxin nanoconjugate for near-infrared fluorescence guided resection of glioblastoma multiforme.聚丙交酯-氯毒素纳米复合物用于近红外荧光引导切除多形性胶质母细胞瘤。
Biomaterials. 2019 Jun;206:146-159. doi: 10.1016/j.biomaterials.2019.03.029. Epub 2019 Mar 23.
3
Receptor occupancy assessment by flow cytometry as a pharmacodynamic biomarker in biopharmaceutical development.

本文引用的文献

1
Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation.尼妥珠单抗是一种靶向表皮生长因子受体的抗肿瘤抗体,它能阻断配体结合,同时保持受体的活性构象。
Cancer Res. 2009 Jul 15;69(14):5851-9. doi: 10.1158/0008-5472.CAN-08-4518. Epub 2009 Jul 7.
2
Validation of a flow cytometry based chemokine internalization assay for use in evaluating the pharmacodynamic response to a receptor antagonist.用于评估对受体拮抗剂药效学反应的基于流式细胞术的趋化因子内化测定法的验证
J Transl Med. 2008 Dec 1;6:76. doi: 10.1186/1479-5876-6-76.
3
在生物制药研发中,通过流式细胞术进行受体占有率评估作为一种药效学生物标志物。
Cytometry B Clin Cytom. 2016 Mar;90(2):117-27. doi: 10.1002/cyto.b.21259. Epub 2015 Jul 31.
Key elements of bioanalytical method validation for macromolecules.
大分子生物分析方法验证的关键要素。
AAPS J. 2007 May 18;9(2):E156-63. doi: 10.1208/aapsj0902017.
4
Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics.用于检测生物治疗药物诱导的中和抗体反应的基于细胞的检测方法的设计、优化和验证建议。
J Immunol Methods. 2007 Apr 10;321(1-2):1-18. doi: 10.1016/j.jim.2006.12.004. Epub 2007 Jan 12.
5
Comparison of sample fixation and the use of LDS-751 or anti-CD45 for leukocyte identification in mouse whole blood for flow cytometry.用于流式细胞术的小鼠全血样本固定以及使用LDS-751或抗CD45进行白细胞鉴定的比较。
J Immunol Methods. 2007 Jan 30;319(1-2):79-86. doi: 10.1016/j.jim.2006.10.016. Epub 2006 Dec 8.
6
Progress in the use of biological assays during the development of biotechnology products.生物技术产品开发过程中生物测定方法的应用进展。
Pharm Res. 2001 Sep;18(9):1239-46. doi: 10.1023/a:1013067424248.
7
Validation in pharmaceutical analysis. Part I: an integrated approach.药物分析中的验证。第一部分:综合方法。
J Pharm Biomed Anal. 2001 Mar;24(5-6):755-67. doi: 10.1016/s0731-7085(00)00530-6.
8
Guidance for robustness/ruggedness tests in method validation.方法验证中稳健性/耐用性测试的指南。
J Pharm Biomed Anal. 2001 Mar;24(5-6):723-53. doi: 10.1016/s0731-7085(00)00529-x.
9
Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective.生物分析免疫测定法的验证:制药行业视角
J Pharm Biomed Anal. 2000 Jan;21(6):1249-73. doi: 10.1016/s0731-7085(99)00244-7.
10
Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity.一种阻断表皮生长因子受体的小鼠单克隆抗体的人源化:拮抗活性的恢复。
Immunotechnology. 1997 Mar;3(1):71-81. doi: 10.1016/s1380-2933(97)00065-1.